E. Davila

发表

Patterns of anthracycline retention modulation in human tumor cells.

C. Vogel, A. Krishan, K. Sridhar, 1987, Cytometry.

Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors

C. Vogel, N. Savaraj, M. Eisenberger, 2004, Investigational New Drugs.

Phase II trial of weekly docetaxel in second‐line therapy for nonsmall cell lung carcinoma

R. Lilenbaum, E. Davila, M. Schwartz, 2001, Cancer.

Multimodality treatment of non‐small cell lung cancer: Response to cisplatin, VP‐16, and 5‐FU chemotherapy and to surgery and radiation therapy

R. Thurer, K. Sridhar, E. Davila, 1988, Journal of surgical oncology.

Inflammatory Breast Cancer

S. Waldman, E. Davila, L. M. Toonkel, 1991 .

Management of locally advanced breast cancer (stage III): a review.

C. Vogel, E. Davila, 1984, International advances in surgical oncology.

Complete Remission of Previously Intractable Peripheral Cutaneous T-Cell Lymphoma of the Lower Extremity Using Isolated Hyperthermic Limb Perfusion with Melphalan (1-Phenylalanine Mustard)

J. Paramo, E. Davila, T. Mesko, 2004, Cancer investigation.

Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma

R. Lilenbaum, J. Lutzky, E. Davila, 2000, Cancer.

High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: a Southeastern Cancer Study Group trial.

A. Bartolucci, E. Davila, P. Desimone, 1986, Cancer treatment reports.

Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)

R. Lilenbaum, E. Davila, L. Siegel, 2000 .

Clinical trial of high‐dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature

S. Hilsenbeck, V. Cairns, C. Vogel, 1988, Cancer.

Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.

B. Kramer, L. Einhorn, A. Bartolucci, 1986, Cancer treatment reports.

Clinical value of the creatinine clearance before the administration of chemotherapy with cisplatin

E. Davila, L. Gardner, 1987, Cancer.

Randomized trial of 3-hour versus 24-hour infusion of high-dose paclitaxel in patients with metastatic or locally advanced breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26.

E. Mamounas, A. Brown, S. Anderson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of glucagon infusion on the renal clearance of amylase relative to creatinine.

F. Tedesco, E. Davila, L. Gardner, 1978, Gastroenterology.

Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25.

D. Wickerham, N. Wolmark, S. Anderson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraductal carcinoma (carcinoma in situ) of the pancreas with microinvasion.

E. Davila, A. Castellano-Sanchez, I. Willis, 1999, Annals of diagnostic pathology.

Phase I trial of misonidazole (NSC#261037) plus cyclophosphamide in solid tumors.

C. Presant, C. Vogel, F. Ostroy, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of gemcitabine and capecitabine in metastatic renal cancer

E. Small, B. Rini, M. Ernstoff, 2006, Cancer.

Efficacy and Safety of Oxaliplatin and Gemcitabine with Bevacizumab in Advanced Non-small Cell Lung Cancer

L. Raez, J. Tseng, R. Lilenbaum, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metastatic germ cell tumor to the heart presenting with syncope

E. Davila, Jaime Burkle, Enma Saiz, 1999, Clinical cardiology.

The Clinical Importance of the Heterogeneity of HER2 neu

E. Davila, K. Amazon, 2010, Case Reports in Oncology.

T-cell lymphoma mimicking granulocytic sarcoma.

M. Borowitz, E. Davila, W. Sternheim, 1985, American journal of clinical pathology.

Phase II trial of oxaliplatin and gemcitabine with bevacizumab in first-line advanced non-small cell lung cancer (NSCLC).

L. Raez, J. Tseng, R. Lilenbaum, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.

C. Presant, J. Carpenter, A. Bartolucci, 1986, Cancer treatment reports.

A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.

E. Small, M. Ernstoff, J. Picus, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ifosfamide-induced encephalopathy.

A. González-Angulo, E. Davila, J. Orzano, 2002, Southern medical journal.

Toxicity of FED Chemotherapy in Non‐small‐Cell Lung Cancer

S. Hilsenbeck, G. Fountzilas, R. Thurer, 1987, American journal of clinical oncology.